New vaccine technology could protect from future viruses and variants
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants
Stay updated with breaking news from Comparative Pathology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals. The studies suggest that a single vaccine with combinations of these antigens – a substance that causes the immune system to produce antibodies against it – could protect against an even greater range of current and future coronaviruses.
Studies of a 'future-proof' vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
The 2023 Albert E. Levy Award for Excellence in Scientific Research went to Jennifer Strafford Stevens and Guido Silvestri in recognition of their groundbreaking research and advancement of scientific knowledge.
Three Harvard Scholars Named University Professors, Highest Faculty Distinction | News | The Harvard Crimson